Thoracic Surgery and Oncology Department

What genetic tests are performed for the department patients?

Researches of EGFR the most common gene mutations are performed for all patients with adenocarcinoma. If it is possible to apply biological therapy, the research of EML4-ALK most common fusion transcripts is performed. There is a possibility to examine all palette of cancer of lungs and the large intestine in the Genetic Diagnostic Laboratory.


Doctors  5        Nurses   11

Total - 23

1095 patients were treated in the department
989 patients were treated for malignant tumor pathology
106 patients were treated for non-malignant pathology

Operational activity

  • Lung resection/VATS 20% - 200
  • Other pulmonary operations - 187
  • Operations of esophagus - 46
  • Image-guided thoracoscopic surgery - 60
  • Operations of pleura - 24
  • Other operations - 175
  • Total: 692

Main projects:

  • The analysis of immune microenvironment and exosomes of non-small cell lung cancer (NSCLC) and its prognostic and predictive value (2016 - 2020, Head S. Cicėnas).
  • Research of factors, affecting the effectiveness of treatment of women with lung cancer (2013 – 2018, Head A. Krasauskas).
  • The significance of polymorphism of types of oncogenic human papillomavirus and some genes that influence the tumor process to efficiency of therapy of oncological patients (2014 – 2018, Consultant S. Cicėnas).

Annual event:  European Regional Conference on Thoracic Oncology is held every year and, during this Conference, lung cancer diagnostic and treatment news are discussed.

Updated 2018-05-02 23:54